MedPath

CHILDREN'S HOSPITAL LOS ANGELES

CHILDREN'S HOSPITAL LOS ANGELES logo
🇺🇸United States
Ownership
Private
Established
1901-04-01
Employees
5K
Market Cap
-
Website
http://www.chla.org

Nebulized Hypertonic Saline for Bronchiolitis

Phase 2
Completed
Conditions
Bronchiolitis
Interventions
Drug: Nebulized 3% saline
Drug: Nebulized 0.9% saline
First Posted Date
2008-02-21
Last Posted Date
2024-11-05
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
447
Registration Number
NCT00619918
Locations
🇺🇸

Children's Hospital & Research Center at Oakland, Oakland, California, United States

🇺🇸

Childrens Hospital Los Angeles, Los Angeles, California, United States

N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma

Phase 1
Completed
Conditions
Neuroblastoma
Interventions
First Posted Date
2007-07-31
Last Posted Date
2023-11-09
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
26
Registration Number
NCT00509353
Locations
🇺🇸

Childrens Hospital Los Angeles, Los Angeles, California, United States

🇺🇸

University of Chicago Comer Children's Hospital, Chicago, Illinois, United States

🇺🇸

Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington, United States

and more 9 locations

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Phase 1
Completed
Conditions
Thrombosis
Heparin-induced Thrombocytopenia
First Posted Date
2006-12-18
Last Posted Date
2015-04-15
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
24
Registration Number
NCT00412464
Locations
🇺🇸

Nationwide Children's Hospital, Columbus, Ohio, United States

🇺🇸

Texas Children's Hospital, Houston, Texas, United States

🇺🇸

Children's Hospital of Orange County, Orange, California, United States

and more 1 locations

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

Phase 3
Conditions
Brain and Central Nervous System Tumors
Interventions
Procedure: autologous bone marrow transplantation
Procedure: autologous hematopoietic stem cell transplantation
Procedure: peripheral blood stem cell transplantation
Radiation: radiation therapy
First Posted Date
2006-10-26
Last Posted Date
2013-12-18
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
120
Registration Number
NCT00392886
Locations
🇺🇸

Childrens Hospital Los Angeles, Los Angeles, California, United States

🇦🇺

Princess Margaret Hospital for Children, Perth, Western Australia, Australia

🇺🇸

Children's Hospital of Orange County, Orange, California, United States

and more 34 locations

Pediatric Fingertip Injuries:Are Antibiotics Required?

Phase 2
Completed
Conditions
Finger Injuries
Interventions
Drug: Cepahlexin (drug)
First Posted Date
2006-03-08
Last Posted Date
2015-04-20
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
146
Registration Number
NCT00300092
Locations
🇺🇸

Childrens Hospitla Los Angeles, Los Angeles, California, United States

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

Phase 1
Completed
Conditions
Neuroblastoma
Interventions
Other: laboratory biomarker analysis
Other: pharmacological study
First Posted Date
2006-02-24
Last Posted Date
2023-04-07
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
80
Registration Number
NCT00295919
Locations
🇺🇸

Childrens Hospital Los Angeles, Los Angeles, California, United States

🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

Children's Hospital Boston, Boston, Massachusetts, United States

and more 8 locations

Vibration Intervention to Improve Bone and Muscle in Children With Cerebral Palsy

Phase 2
Completed
Conditions
Cerebral Palsy
Interventions
Other: Standing
Device: High frequency, low magnitude vibration
First Posted Date
2006-02-23
Last Posted Date
2024-01-10
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
34
Registration Number
NCT00295295
Locations
🇺🇸

Children's Hospital Los Angeles, Los Angeles, California, United States

N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma

Phase 2
Completed
Conditions
Neuroblastoma
Interventions
Biological: Filgrastim
Procedure: Peripheral blood stem cell infusion
Radiation: 131I-MIBG
Radiation: Radiation therapy
First Posted Date
2005-11-15
Last Posted Date
2023-04-10
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
50
Registration Number
NCT00253435
Locations
🇺🇸

AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta, Georgia, United States

🇺🇸

Childrens Hospital Los Angeles, Los Angeles, California, United States

🇺🇸

University of Chicago Comer Children's Hospital, Chicago, Illinois, United States

and more 12 locations

Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia

Phase 4
Completed
Conditions
Growth Hormone Deficiency
Hypopituitarism
Septo-Optic Dysplasia
Interventions
First Posted Date
2005-09-01
Last Posted Date
2015-04-01
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
20
Registration Number
NCT00140413
Locations
🇺🇸

Childrens Hospital Los Angeles, Los Angeles, California, United States

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Phase 1
Completed
Conditions
Diarrhea
Drug/Agent Toxicity by Tissue/Organ
Neuroblastoma
First Posted Date
2004-10-08
Last Posted Date
2010-10-15
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
30
Registration Number
NCT00093353
Locations
🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

Children's Hospital Los Angeles, Los Angeles, California, United States

🇺🇸

Indiana University Cancer Center, Indianapolis, Indiana, United States

and more 10 locations
© Copyright 2025. All Rights Reserved by MedPath